Outlook Therapeutics OTLK

$ 0.22 -7.74%

Quarterly report 2025-Q4
added 02-17-2026

Outlook Therapeutics DIO Ratio 2011-2026 | OTLK

Quarterly DIO Ratio Outlook Therapeutics

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
10.5 K	-	802	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10.5 K	802	5.63 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Esperion Therapeutics ESPR	2.46 K	$ 3.13	0.55 %	$ 651 M	USA
	Exelixis EXEL	96.1	$ 48.2	8.51 %	$ 13.1 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Fortress Biotech FBIO	210	$ 2.53	2.85 %	$ 70.6 M	USA
	Galapagos NV GLPG	0.915	$ 28.81	1.48 %	$ 2.69 B	Belgium
	Grifols, S.A. GRFS	0.000171	$ 8.4	1.63 %	$ 6.83 B	Spain
	Ionis Pharmaceuticals IONS	259	$ 77.0	2.33 %	$ 12.3 B	USA
	Kamada Ltd. KMDA	166	$ 8.29	0.91 %	$ 260 M	Israel
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Ligand Pharmaceuticals Incorporated LGND	235	$ 231.58	-0.31 %	$ 4.24 B	USA
	ACADIA Pharmaceuticals ACAD	295	$ 22.58	1.03 %	$ 3.74 B	USA
	MannKind Corporation MNKD	430	$ 3.61	26.17 %	$ 1.1 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.0	2.46 %	$ 3.05 B	USA